December 1st 2023
The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.
October 13th 2016
Among other findings: Shared genetic factors may account for 91% of the association between adult ADHD and binge eating.
September 29th 2016
Of the [ADHD] drug's effects he said, "It was instant; it fixed everything...All these problems that had ailed me my whole life were gone."
September 20th 2016
A new study on gender differences in ADHD-depression overlap found each ADHD symptom significantly worsened depression.
The relative risk of CV events with methylphenidate is generally low; however risk of MI may be higher in the early days after initiation.
6 New Drugs Approved for Primary Care: Q2 2021
From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.
10 New Drugs for Primary Care: Q1 2019
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.
9 Brand New Drugs for Primary Care
COPD… nasal polyps.. gout …. dyskinesia in Parkinson Disease: here’s a brief look at new drugs for these and other disorders coming your way.
Growth Charting May Aid in Early Identification of ADHD
A first-of-its-kind study applies traditional growth-charting to evaluate abnormal developmental patterns in connectivity networks of a child's brain.
Moderate Exercise Tied to Improved ADHD Symptoms in Young Men
Most significant were positive changes in motivation to complete mental work and in vigor, fatigue, and depression.
ADHD: What’s Myth and What’s Fact?
ADHD: seen only in kids; boys are more impaired vs girls; only stimulants work. Myths or facts?
ADHD in Adults: A Quiz for Primary Care
What does ADHD look like in adults? What signs/symptoms should be on your radar? Find out what you know and what you need to know.
A Case of Attention Deficit Disorder?
Attention to ADD seems to be escalating. It almost seems to be a fad. Doesn’t everyone want to be able to focus better?
Mini-Quiz: ADHD and Oppositional Behaviors
Attention-deficit/hyperactivity disorder and oppositional defiant disorder are both considered disruptive behavior disorders, but the 2 disorders are distinct, having different etiologies and responding to different types of treatment.
Pediatricians Issue Dangerous New Treatment Guidelines for Attention Deficit Disorder
Despite its caveats and good intentions, the AAP guideline will surely invite an inappropriate glut of medication for preschoolers . . .
ADHD & ODD: Confronting the Challenges of Disruptive Behavior
About half of children with ADHD also meet the diagnostic criteria for ODD but the disorders have different etiologies and respond to different types of treatment.
ADHD in Adults: How to Recognize-and Treat
In the past 15 years, there has been an increasing awareness of the syndromal persistence of attention-deficit/ hyperactivity disorder (ADHD) into adulthood.
Boy With Extraordinarily High Blood Lead Levels
A 9-year-old asymptomatic boy was referred to our tertiary care facility with a blood lead level (BLL) of 59 μg/dL. A diagnosis of attention deficit hyperactivity disorder, which was managed with amphetamine/dextroamphetamine, had been made when the patient was 6 years old.
Study Provides Snapshot of ADHD Prevalence in U.S. Children
CINCINNATI -- Almost 9% of U.S. children ages 8 to 15 meet standard diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD), but less than half of them receive treatment.
Drug Boosts Performance of Poor Sleepers with ADHD
MONTREAL -- For children with attention-deficit hyperactivity disorder who sleep poorly, methylphenidate (Ritalin) helps make them alert when they are awake.
ADHD Therapies Hold Roughly Uniform Benefit in the Long Run
NEW YORK -- Most kids with attention deficit hyperactivity disorder (ADHD) get better over time with treatment, regardless of what that treatment is, according to observational follow-up of a major study.
APA: Co-Morbid ADHD in Bipolar Adults May Respond To Non-Stimulants
SAN DIEGO -- When attention deficit hyperactivity disorder meets bipolar disorder in an adult, the diagnosis is hard and the course is poorly understood but the co-morbidity appears to exacerbate matters, researchers said here.
USPSYCH: Concurrent Treatment Works for ComorbidADHD and Substance Abuse
SAN FRANCISCO -- Given the high prevalence of substance abuse in patients with attention deficit hyperactivity disorder (ADHD), psychiatrists need to consider comorbidity in assessment of both conditions.
ADHD Drug Designed to Limit Abuse Wins FDA Okay
ROCKVILLE, Md. -- The FDA has approved lisdexamfetamine dimesylate (Vyvanse), formerly known as NRP104, for attention deficit hyperactivity disorder.
FDA Orders ADHD Drug Advisories for Patients
ROCKVILLE, Md. -- The FDA has ordered all drugs approved for attention deficit hyperactivity disorder to carry guides to inform patients about the potential for cardiovascular risks and adverse psychiatric symptoms.
USPSYCH: Daily Coaching and Professional Organizers May Help With ADHD
NEW ORLEANS -- Although pharmacological treatments are the mainstay of therapy for attention-deficit hyperactivity disorder (ADHD) in adults, psychosocial treatments can be a useful adjunct and improve patients' quality of life.
USPSych: ADHD In Teens and Adults: A Different Disease With Sterner Consequences
NEW ORLEANS -- Attention-deficit hyperactivity disorder (ADHD), often thought of as a condition of childhood, may persist into adolescence and adulthood, causing serious life problems, investigators said here.
AACAP: Investigational Pediatric ADHD Agent Aims at Reduced Abuse Potential
SAN DIEGO -- An investigational d-amphetamine prodrug appears to be effective in treating pediatric attention deficit hyperactivity disorder, with the goal of less abuse potential than amphetamines, researchers said.
AACAP: Growth Reduction Seen Temporary for Children on ADHD Drug
SAN DIEGO, Calif. -- Strattera (atomoxetine) given to children with attention deficit hyperactivity disorder does not appear to stunt growth over the long term, according to a lengthy study.
Overdoses of ADHD Drugs Lead to Many ER Visits
ATLANTA ? Stimulants used to treat attention deficit-hyperactivity disorder (ADHD) that are accidentally overdosed or trigger adverse reactions lead to more than 3,000 emergency room visits a year, estimate CDC researchers.
2 Clarke Drive Cranbury, NJ 08512